The global gastrointestinal stents market size is expected to reach USD 611.4 million by 2030, registering a CAGR of 5.2% during the forecast period, according to a new report by Grand View Research, Inc. Increasing burden of gastrointestinal diseases including biliary diseases, esophageal cancer, and colorectal cancer are anticipated to boost the usage of GI stents across the globe.
Individuals above 60 years of age form the key target population for these products, as they are at a high risk of developing gastrointestinal and stomach-related diseases. Thus, aging demographics of most of the economies around the globe is a prime factor driving the growth of the sector. Moreover, reimbursement coverage provided by the Center for Medicare & Medicaid Services (CMS) and various private payers is spurring the adoption of GI stents.
Request a free sample copy or view report summary: Gastrointestinal Stents Market Report
The gastrointestinal stents market study suggests that biliary stent dominated the overall sector in 2023. Incidences of biliary diseases such as bile duct cancer, gallstone disease and primary biliary cholangitis are on the rise globally, which would drive the growth of biliary stents sector positively.
Duodenal stents are projected to emerge as the fastest-growing segment during the forecast period. Attributed to the rising gastrointestinal disorders such as tumors, strictures, and other pathologies.
North America occupied the largest revenue share in 2023, due to the high rate of diagnosing new cases of gastrointestinal diseases and constantly rising awareness regarding commercial availability of effective treatments.
In addition, increasing incidences of irritable bowel syndrome, colorectal cancer and pancreatic cancer are a few high impact-rendering drivers for the market.
Asia Pacific is expected to witness a significant growth during the forecast period. The presence of countries such as Japan, China and India with constantly increasing patient population is a key factor anticipated to fuel the market growth in the region.
Grand View Research has segmented the global gastrointestinal stents market based on type, application, material, end-use, and region:
Gastrointestinal Stents Type Outlook (Revenue, USD Million, 2018 - 2030)
Biliary Stent
Esophageal Stent
Colonic Stent
Pancreatic Stent
Duodenal Stent
Gastrointestinal Stents Application Outlook (Revenue, USD Million, 2018 - 2030)
Gastrointestinal Cancer
Biliary Disease
Colorectal Cancer
Stomach Cancer
Others
Gastrointestinal Stents Material Outlook (Revenue, USD Million, 2018 - 2030)
Metal
Plastic
Others
Gastrointestinal Stents End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Ambulatory Surgical Centers
Others
Gastrointestinal Stents Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Gastrointestinal Stents Market
Boston Scientific Corporation
Olympus Corporation
CONMED Corporation
Cook Medical
Medtronic
ELLA
Cantel Medical Corporation
Merit Endotek
Hobbs Medical, Inc.
Gore Medical
"The quality of research they have done for us has been excellent..."